96 reports

LONZA: OPPORTUNITY ASSESSMENT Opportunity Assessment Merck delivers novel health solutions through its prescription medicines, biologic therapies, and consumer care products.

  • Biological Therapy
  • World
  • Forecast
  • Merck & Co., Inc.
  • Sanofi S.A.

Glybera approved in Germany in 2015 for the treatment of rare blood condition with gene therapy costs about atleast $## million per treatment.

  • Biological Therapy
  • World
  • Market Size
  • Eppendorf AG
  • GE Healthcare Limited
  • MARKET DYNAMICS FOR GLOBAL CANCER BIOLOGICAL THERAPY MARKET
  • 6 Global Cancer Biological Therapy Market, By Type

Cancer is the leading and second largest cause of death across the globe. The disease is characterized by disordered and deregulated cellular and stromal explosion along with reduced cell death and growth factor deprivation, and such other factors. There are many biological therapies that have been approved and being used by various cancer...

  • Biological Therapy
  • World
  • Forecast
  • Market Size
  • Pfizer Inc.

The application of biosimilars in blood disease treatment is one of the highest revenue generating segment owing to the high-priced reference biologics and frequent application.

  • Biological Therapy
  • Biopharmaceutical
  • Biosimilar
  • Pharmaceutical
  • World

Hence to the patient. to manufacture one dose of autologous therapy would cost USD ##-##.

  • Biological Therapy
  • Biopharmaceutical
  • Biotechnology
  • Vaccine
  • World

Biologics: Targets and Therapy; ##(##): ##-##.

  • Biological Therapy
  • Cancer Immunotherapy
  • Therapy
  • Vaccine
  • World

Chemotherapy may be used alone or with RT or a biological therapy.

  • Biological Therapy
  • Leukemia
  • Monoclonal Antibody
  • Therapy
  • World

The multi-modality treatment of cancer may include surgery, chemotherapy, biological therapy, or radiation therapy.

  • Biological Therapy
  • World
  • Carl Zeiss Meditec AG
  • Eckert & Ziegler AG
  • Varian Medical Systems, Inc.

EXPERT OPINION ON BIOLOGICAL THERAPY; ##(##): ##-##.

  • Biological Therapy
  • Epidemiology
  • Therapy
  • Transplantation
  • World

In Europe, the EC is one of the governmental organization that funds for biologicals research and development.

  • Biological Therapy
  • Cell Therapy
  • Therapy
  • Tissue Engineering
  • World

Gene therapies segment is expected to be the fastest emerging technology due to tremendous potential of gene therapy in minimizing immune rejections, which commonly occur after transplantations.

  • Biological Therapy
  • Molecular Biology
  • Tissue Engineering
  • World
  • Market Size

SAMSUNG BIOLOGICS' PLANT ### CAME INTO OPERATION IN MAY 2011.

  • Biological Therapy
  • Biopharmaceutical
  • Cell Therapy
  • Manufacturing
  • World

Leucotropin is a highly purified preparation of a monomeric, biologically active molecule.

  • Biological Therapy
  • Clinical Trial
  • Hospital
  • Lymphoma
  • World

It is comprised of the delivery of a therapeutic gene, protein Phosphatase-## Inhibitor-## (I- ##) with the use of Biological NanoParticles (BNPs) and the Self-Complementary Vector Technology.

  • Biological Therapy
  • World
  • Bioheart, Inc.
  • Celladon Corporation
  • GlaxoSmithKline plc

Following one year of AAT treatment, there will be a one-year follow-up.

  • Biological Therapy
  • Insulin
  • Type 1 Diabetes
  • World
  • Company
  • Global Cytokine Market in USD million, by Therapeutic Application, 2014 to 2022

There is an increase in access and acceptance of the cytokines immunotherapy, a type of biological therapy to treat cancer.

  • Biological Therapy
  • Cytokine
  • United States
  • World
  • Market Size

The CBER regulates biologics including allergenic extracts blood and blood components, gene therapy products, devices and test kits human tissue and cellular products used in transplantation and vaccines.

  • Biological Therapy
  • Cell Therapy
  • World
  • Market Size
  • Selexis SA

The CBER regulates biologics including allergenic extracts blood and blood components, gene therapy products, devices and test kits human tissue and cellular products used in transplantation and vaccines.

  • Biological Therapy
  • Cell Therapy
  • World
  • Market Size
  • Selexis SA

The company' s product portfolio includes biologics, prescription pharmaceuticals and vaccines.

  • Biological Therapy
  • Pharmaceutical
  • Therapy
  • United States
  • World

Using a Bayesian statistical analysis, there was high posterior probability (##%) that the ACR## RR of bimekizumab at Week ## was greater than those reported for current standard of care biologic treatments, including anti-IL-##A therapies.

  • Biological Therapy
  • Cytokine
  • Interleukin
  • Therapy
  • World
  • PIPELINE BY SYNTRIX BIOSYSTEMS INC, H1 2018

After ## week without therapy, combined therapy is resumed at the beginning of week ##.

  • Biological Therapy
  • Breast Cancer
  • Therapy
  • Transplantation
  • World

Hoffmann-La Roche Ltd ## ## ## ## ## ## ## ## Progenics Pharmaceuticals Inc ## ## ## ## ## ## ## ## United Therapeutics Corp ## ## ## ## ## ## ## ## Novartis AG ## ## ## ## ## ## ## ## APEIRON Biologics AG ## ## ## ## ## ## ## ## Pfizer Inc ## ## ## ## ## ## ## ## Y-mAbs Therapeutic

  • Biological Therapy
  • Clinical Trial
  • Oncology
  • Therapy
  • World

The company' s product portfolio includes biologics, prescription pharmaceuticals and vaccines.

  • Biological Therapy
  • Pharmaceutical
  • Therapy
  • United States
  • World
  • 2.8 Allergy Immunotherapy: An Overview

Yet the market faces some challenges such as, lack of treatment awareness, lack of investor confidence, anaphylaxia, huge treatment costs, etc. ##.

  • Allergy Immunotherapy
  • Biological Therapy
  • World
  • Market Size
  • Allergy Therapeutics plc

One patient showed imaging evidence suggestive of antitumor biological activity.

  • Biological Therapy
  • Breast Cancer
  • Colony-Stimulating Factor
  • Therapy
  • World

Qu Biologics plans to initiate a larger follow-on clinical trial in Crohn' s disease in late 2017/ early 2018 with a ##-week QBECO SSI treatment period.

  • Biological Therapy
  • Clinical Trial
  • Digestive System Disorder
  • Monoclonal Antibody
  • World

THE PROLONGED INHIBITION OF IL-## ALPHA AND IL-## BETA IN THE ## AND ## MG/ KG GROUPS INDICATED A LONG LASTING BIOLOGICAL EFFECT OF ABT-##.

  • Biological Therapy
  • Cytokine
  • Hospital
  • Therapy
  • World

HYQVIA OFFERS A DEMONSTRATED SAFETY AND EFFICACY PROFILE WHILE DELIVERING A FULL DOSE OF TREATMENT VIA ONE NEEDLE, ONE INFUSION SITE, ONCE PER MONTH.

  • Biological Therapy
  • Genetic Disorder
  • Hospital
  • World
  • ADMA Biologics, Inc.

XBiotech' s True Human antibody, MABp##, is expected to have the smallest immunogenic footprint possible for a biological drug.

  • Biological Therapy
  • Therapy
  • World
  • Product Initiative
  • XBiotech Inc.

For instance: In March 2015, the Centre for Process Innovation (CPI) (U. K. ) received USD ##. ## million (GBP ##. ## million) from the Government' s Advanced Manufacturing Supply Chain Initiative (AMSCI) to support the development and manufacture of novel biologic treatments.

  • Biological Therapy
  • Cell Therapy
  • World
  • Market Size
  • Becton Property Group